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ADAMTS13 expression in human chondrosarcoma cells induced by insulin
Insulin tarafindan indüklenmiş insan kondrosarkom hücrelerinde ADAMTS13 ekspresyonu
Rıdvan Fırat1, Sümeyya Akyol2, S. Fatih Kurşunlu3, Veli Uğurcu4, Gönül Erden5, Özlem Çakmak6, Kadir Demircan7
ÖZET
Amaç: A Disintegrin-like Metalloproteinase with Throm-
bospondin Motifs (ADAMTS) proteinleri esas olarak eks-
traselüler matrikste (ECM) bulunan bir ptoteinaz enzim 
grubudur. İnsülinin kondrosarkom kondrositlerinde prote-
oglikan sentezini stimüle ettiği uzun yıllardır bilinmektey-
di. Dolayısıyla bu çalışmanın amacı insülinin, OUMS-27 
insan kondrosarkom hücre kültüründeki zaman bağımlı 
etkilerini değerlendirmek ve insülinin anabolik etkilerinden 
dolayı ADAMTS13 ekspresyonunu azaltma ihtimali hipo-
tezini test etmektir.
Yöntemler: Bu hipotezi test etmek için OUMS-27 hücre-
lerinin, 10μg/mL insulin içeren Dulbecco’s modified Eagle 
besiyerinde (DMEM) kültürü yapıldı. 11. güne kadar iki 
günde bir besiyeri ile birlikte insülin takviyesi yapıldı. Hüc-
reler 1, 3, 7 ve 11. günlerde harvest edilerek uygun za-
manlarda protein ve RNA izolasyonu yapıldı. ADAMTS13 
RNA ekspresyonu uygun primerler kullanılarak qRT-PCR 
yöntemi ile ölçüldü ve anti-ADAMTS13 antikorları kulla-
nılarak Western blot yöntemi ile protein miktarı ölçüldü.
Bulgular:  Kontrol  grubu  ile  karşılaştırıldığında  insülin 
uygulanan hücre gruplarında, hem RNA hem de protein 
miktarı azaldı ancak bu istatistiksel olarak anlamlı değildi.
Sonuç: Bu bulgular ışığında insülinin OUMS-27 kondro-
sarkom  hücrelerinde ADAMTS13  regülasyonuna  pozitif 
ya da negative herhangi bir etki yapmadığı sonucu ortaya 
çıkmıştır.
Anahtar kelimeler: İnsulin, ADAMTS13, Kondrosarkom, 
OUMS-27, RNA
ABSTRACT
Objective:  A  Disintegrin-like  Metalloproteinase  with 
Thrombospondin Motifs (ADAMTS) proteins is a protein-
ase enzyme group that primarily located in the extracel-
lular matrix (ECM). Insulin has been known to stimulate 
proteoglycan biosynthesis in chondrosarcoma chondro-
cytes and thereby the levels of ADAMTS proteins. The 
aim of this study is to evaluate the time-dependent effects 
of insulin on the ADAMTS13 expression in OUMS-27 hu-
man chondrosarcoma cell line to test the hypothesis that 
insulin diminishes ADAMTS13 expression because of its 
anabolic effects.
Methods: To test this hypothesis OUMS-27 cells were 
cultured in Dulbecco’s modified Eagle’ medium (DMEM) 
containing 10μg/mL insulin. The medium containing in-
sulin was changed every other day up to 11th day. Cells 
were harvested at 1, 3, 7, and 11th days and protein and 
RNA isolations were performed at the proper times. The 
levels of RNA expression of ADAMTS13 was quantified 
by qRT-PCR using appropriate primers while protein lev-
els was detected by Western blot technique using anti-
ADAMTS13 antibody. 
Results: Although there was a decrease in both RNA and 
protein levels in insulin-applied groups compared to the 
control cells, it was not statistically significant.
Conclusion: Under  the light  of our  findings,  it is sug-
gested that insulin does not participate in regulation of 
ADAMTS13 in OUMS-27 chondrosarcoma cells. J Clin 
Exp Invest 2014; 5 (2): 226-232
Key words:  Insulin;  ADAMTS13,  chondrosarcoma, 
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INTRODUCTION
Chondrosarcoma  is  a  cancer  composed  of  cells 
that produce cartilage. It is the third frequent pri-
mary cancer of bone. Most of the time these tumors 
are not aggressive and metastasize is not common, 
and they have good prognosis after surgery [1]. Its 
incidence increases after fourth decade. They syn-
thesize and secrete some of A Disintegrin-like Me-
talloproteinase  with  Thrombospondin  Motifs  (AD-
AMTS) proteins. This proteinase enzyme group is 
primarily located in the extracellular matrix (ECM). 
It is a member of Matrix Metalloproteinase (MMP) 
family in the ECM that breaks substrates such as 
agrecan, versican, brevican, nidogen, and procolla-
gen. It has 19 members and different functions have 
been identified for each member. They are involved 
in  many  physiological  processes  including  ECM 
turnover, coagulation, angiogenesis and ovulation, 
as well as pathological processes such as arthritis, 
atherosclerosis, and cancer.
ADAMTS13,  popularly  known  as  von  Wille-
brand factor cleaving protease (vWFCP), does not 
belong to any other sub-groups and is one member 
of the ADAMTS family [2]. ADAMTS13 is primarily 
produced and released from hepatic stellate cells 
[3-5], and endothelial cells [6,7].
ADAMTS13  is  an  important  protein/enzyme 
and has a therapeutic interest because it is the tar-
get gene in thrombotic thrombocytopenic purpura 
(TTP) [8]. Pathological processes such as angiogen-
esis is also a topic of interest. Because ADAMTS13 
is expressed in endothelial cells it is thought it has 
an important role in angiogenesis. In various stud-
ies, it has been suggested that ADAMTS13 inhibit 
vascular  endothelial  growth  factor  (VEGF)  medi-
ated angiogenesis [9], and ADAMTS13 activity is 
decreased  at  malignant  patients  [10].  Addition-
ally, abnormal ADAMTS13 production is shown in 
obese patients [11]. In another study, it is concluded 
that, ADAMTS13 might be associated with diabetic 
nephropathy  [12].  Hugenholtz  et  al.  showed AD-
AMTS13 levels were decreased at acute liver fail-
ure [13]. Studies have demonstrated that reduced 
plasma ADAMTS13 activity and increased plasma 
VWF are risk factors for the occurrence of myocar-
dial infarction [14-16], ischemic stroke [17-19], and 
preeclampsia [20].
Insulin is an anabolic hormone that stimulates 
the uptake of glucose to the muscle and fat cells, 
boots the conversion of glucose to glycogen or fat 
for storage, inhibits glucose production by the liv-
er, prompts protein synthesis, and inhibits protein 
breakdown [21]. Metabolic effects of insulin are well 
known but the molecular mechanism of insulin ac-
tion in many cells is not fully understood [22,23]. For 
its action, binding of insulin to specific receptors in 
the plasma membrane is accepted as the first step. 
Using anti-insulin-receptor antibodies, it was found 
that  insulin  stimulates  proteoglycan  synthesis  via 
the insulin receptor [24]. One of preceding papers 
also demonstrated that insulin stimulates proteogly-
can biosynthesis in rat chondrosarcoma chondro-
cytes [25].
Generally, ADAMTS show a proteoglycan de-
grading effect. Because ADAMTS13 is a member of 
ADAMTS family, we hypothesized that insulin induc-
tion to chondrocytes might decrease the RNA and 
protein amount of ADAMTS13. Therefore, the goal 
of this study was to evaluate the time-dependent 
effects of insulin on the chondrogenic ADAMTS13 
expression to test the hypothesis that insulin act in 
a prohibitive manner to prevent ADAMTS13 expres-
sion.
METHODS
OUMS-27  cell  culture:  OUMS-27  chondrosarco-
ma cells were kindly provided by Dr. T. Kunisada 
(Okayama  University  Graduate  School  of  Medi-
cine and Dentistry, Okayama, Japan). Cells were 
cultured  in  Dulbecco’s  modified  Eagle’s  medium 
(DMEM)  containing  10%  fetal  bovine  serum  and 
penicillin/streptomycin at 37 °C in a humidified atmo-
sphere of 5% CO2 in air. The cells were subcultured 
at split ratios of 1:2-1:4 using trypsin plus EDTA ev-
ery 7-10 days. Cells were used at passages 7-14 for 
all experiments. The medium was changed every 
other day with either control media or control media 
supplemented with 10 μg/mL insulin for a total of 
11 days. Four groups of cells (two of each group, 
one for qRT-PCR and one for Western blot analysis) 
were subjected to insulin: For 1st day experiment, 
2x105 cells, for 3rd day experiment 1x105 cells, for 
7th day experiment 5x104 cells, and 3x104 cells were 
plated in 20-mm dishes and exposed to the different 
concentrations of insulin at the days indicated. After 
the experiment, cells were harvested and total RNA 
and protein isolation were made.
Total RNA isolation
Total RNA was extracted with TRIzol (Invitrogen) ac-
cording to the manufacturer’s instructions. Two mi-
crogram RNA were reverse transcribed with Rever 
Tra Ace (Thermo) and random hexamers (Thermo) 
with random primers according to the manufactur-Fırat et al. ADAMTS13 expression in human chondrosarcoma cells 228
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er’s instruction (Table 1). Human GAPDH was am-
plified as a control for the PCR reaction. Samples 
lacking reverse transcriptase were amplified as a 
control  for  genomic  DNA  contamination.  RNase-
free water was used to elute total RNA from each 
sample. UV spectrophotometry was used to quan-
tify and determine the purity of each sample. Sam-
ples required a 260/280 ratio of 2.0 and a 260/230 
ratio of 1.7 for adequate purity.
Real-time PCR
qRT-PCR  was  performed  on  cDNA  samples  ob-
tained (Qiagen) as described in our previous report 
[26]. Total RNA RT-PCR section uses the intercalat-
ing dye SYBR green (Qiagen) in the presence of 
primer pairs. The PCR mixture consisted of SYBR 
Green PCR Master Mix, which includes DNA poly-
merase, SYBR Green I Dye, dNTPs including dUTP, 
PCR buffer, 10 pmol forward and reverse primers 
and cDNA of samples in a total volume of 20 μL. 
The amplification of a housekeeping gene, GAPDH, 
was  used  for  normalizing  the  efficiency  of  cDNA 
synthesis and the amount of RNA applied. PCR was 
performed with initial denaturation at 95 °C for 5min, 
followed by amplification for 40 cycles, each cycle 
consisting of denaturation at 95 °C for 10 s, anneal-
ing at 57 °C for 30 s, polymerization at 72 °C for 30 
s and, the last stage, polymerization at 72 °C for 5 
min. The results pertaining to ADAMTS13 were rep-
resented as graphics. The bars and error bars rep-
resent mean and standard deviation, respectively. 
Protein Extraction, Western Blot Analysis, 
and Antibodies
After stimulation, the cells were washed once with 
PBS and then scraped from the plates. Cells were 
solubilized in 300 μL of CelLytic TMM (Sigma) with a 
protease inhibitor mixture. After incubation in a rota-
tor at 4 °C for 15 min, the samples were centrifuged, 
and the supernatants were collected. The protein 
concentration of the cell extracts was determined 
using a protein assay kit (Thermo Scientific Brad-
ford Assay Kit) and standard bovine serum albumin. 
Protein samples were boiled at 95 °C within Laemli 
Sample buffer and β-merkaptoethanol for 8 min. Ten 
micrograms of total protein were used for Western 
blot analysis. Briefly, 10 μL of each sample includ-
ing protein marker (BioRad Precision Plus Protein 
Western C Standard) were loaded to Western blot 
gel (BioRad Mini-PROTEAN TGX Stain-Free Gels, 
4–15%, 15-well comb, 15 μL) within BioRad 1X Tris/
Glycerine/SDS running buffer and run at 250 V for 
20 min. After electrophoresis, proteins were trans-
ferred  onto  polyvinylidene  difluoride  membranes 
(BioRad Trans-Blot Turbo Transfer Pack, 0.22 μM 
PVDF) by using transfer system (BioRad Trans-Blot 
Turbo  Transfer  System,  Singapore).  Membranes 
were blocked for 1 h in 2.5% nonfat dried skim milk 
in TBS containing 0.05% Tween 20 (TBST). The 
membranes  were  incubated  overnight  (16  hours) 
with primary anti-ADAMTS13 and anti-GAPDH anti-
bodies (Table 2) diluted in blocking buffer. After strin-
gent washing with TBST three times for 8 min each 
at room temperature, the membranes were incubat-
ed 1 hour with the appropriate secondary antibodies 
(Table 2). Following three successive washes with 
TBST, immunoreactive bands were visualized using 
the enhanced chemiluminescence system (BioRad 
Immun-Star Western C kit) for 90 second. Signals 
were  detected  with  BioRad  ChemiDoc  MP  Imag-
ing System (Singapore), and the densitometry was 
performed with Image J software (W. Rasband, Re-
search Services Branch, NIMH, National Institutes 
of  Health,  Bethesda,MD)  and  normalized  to  the 
signal intensity of GAPDH for equal protein load-
ing control of each sample in each experiment. This 
quantification was performed with the linear range 
of the standard curve defined by the standard sam-
ple, GAPDH, for all densitometry analysis.
ADAMTS13
Forward TGCACCTGGTGAAGATGGTC
120 bp product
Reverse CGTCCTCAGGGTTGATGGTC
GAPDH
Forward CCTGCACCACCAACTGCTTA
108 bp product
Reverse TCTTCTGGGTGGCAGTGATG
Table 1. The forward and reverse 
primers used in the real-time poly-
merase  chain  reaction  analyses 
for ADAMTS13 and GAPDH
Primary Ab
Primary Ab
concentration
Secondary Ab
Secondary Ab
concentration
Reaction kDa
ADAMTS13 1/1000 Goat 1/4000 Mouse, rat, human 85-110
GAPDH 1/10000-1/50000 Rabbit 1/4000 Human 36
Table 2. Primary 
and  secondary 
antibodies  used 
for  Western  blot 
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Statistical analyses
Statistical Package for Social Studies version 16.0 
was  used  for  all  statistical  tests.  Nonparametric 
Kruskal Wallis test were applied. The relationships 
between the variables were tested by Mann-Whit-
ney U test. p<0.05 was accepted as significant.
RESULTS
Expression levels of ADAMTS13 in insulin-induced 
OUMS-27  chondrosarcoma  cell  lines  were  ana-
lyzed  by  using  qRT-PCR  and  Western  blot  tech-
niques. The results were represented as graphics. 
In qRT-PCR results, the bars in the graphics repre-
sent the means of ADAMTS13 expression (as AD-
AMTS13/GAPDH ratio) and the error bars represent 
the standard deviation of means. qRT-PCR cycle 
quantitation and standard concentration graphics of 
ADAMTS13 can be shown in Figure 1. There was 
difference between control cells and insulin-induced 
cells in terms of ADAMTS13/GAPDH ratio (Figure 
2) but it was not statistically significant. Two protein 
bands for ADAMTS13 were detected in Western blot 
analysis: 115 kDa and 50 kDa (Figure 3). According 
to the first band, there was a sharp decrease (ap-
proximately 2-fold) in protein amount of ADAMTS13 
at the day 1 after insulin induction. We can see this 
decrease in band 2 as well (about %25 decrease 
in protein levels). When the protein levels in con-
Figure 1.  qRT-PCR  cycle  quantitation 
and standard concentration graphics of 
ADAMTS13
Figure 2. The results of ADAMTS13 qRT-PCR calcula-
tions of 5 different experiments. The values were stan-
dardized by division of ADAMTS13 to GAPDH. There is 
no statistically significant difference between the groups.Fırat et al. ADAMTS13 expression in human chondrosarcoma cells 230
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trol group was adjusted to the value ‘1’, the protein 
values were found to be 0.83, 0.75, and 0.83 in the 
days of insulin induction 3, 7, and 11, respectively, 
in the first band (115 kDa) detected. According to 
the second 50 kDa band, there was a sharp de-
crease at 1st day of insulin induction (about 25%), 
but after that, there was no decrease at 3th day, but 
a gradual increase up to 50% at 11th day.
Figure 3.  Immunoreac-
tive  protein  bands  de-
tected  by  Western  blot 
technique of ADAMTS13 
and  GAPDH.  The  bar 
graphics  of  calculated 
band  densities  of  both 
two  ADAMTS13  bands 
and  GAPDH.  The  ob-
tained values were stan-
dardized  by  division  of 
ADAMTS13 to GAPDH
DISCUSSION
There were only a few studies in the literature about 
the effect of insulin on the human chondrosarcoma 
cell lines. Moreover, there has been no study on the 
expression levels of ADAMTS13 in insulin-induced 
OUMS-27  chondrosarcoma  cells,  even  in  normal 
chondrocytes to detect the RNA and/or protein lev-
els of this enzyme up to now. This report is the first 
one  that  shows  the  expression  of ADAMTS13  in 
both  chondrocytes  from  human  chondrosarcoma 
and insulin-induced chondrosarcoma cells. Accord-
ing to the results of the present study, there was 
no significant difference between control chondro-
sarcoma  cells  and  insulin-induced  chondrosar-
coma cells in terms of RNA and protein levels of 
ADAMTS13.
The  studies  on  ADAMTS13  were  focused 
mostly on the processing of von Willebrant factor by 
this ADAMTS enzyme. At the first time, vascular en-
dothelial-produced von Willebrant factor was found 
to be cleaved and degraded into smaller parts by 
a specific plasma protease [27]. Severe deficiency 
of plasma ADAMTS13 activity results in thrombotic 
thrombocytopenic  purpura  while  mild  to  moder-
ate deficiencies of plasma ADAMTS13 activity are 
emerging risk factor for developing myocardial and 
cerebral  infarction,  pre-eclampsia,  and  malignant 
malaria [28]. Lately, systemic administration of AD-
AMTS13 (20 min after surgery, 100 μg per 10 gram 
body weight) was found to reduce neuronal injury 
after experimental subarachnoid hemorrhage (SAH) 
by reducing microthrombosis formation and neuro-
nal inflammation, thereby providing a new option for Fırat et al. ADAMTS13 expression in human chondrosarcoma cells 231
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mitigating the severity of neuronal injury after SAH 
[29]. There are several studies focused on the effect 
of ADAMTS13 in organ injuries/deficiencies rather 
than blood coagulation disorders. ADAMTS13 was 
found to have a critical role in the central nervous 
system, particularly after neuronal injuries, because 
of the fact that ADAMTS13 was expressed in cul-
tured astrocytes and microglia but not in neurons 
[30]. ADAMTS13 deficiency due to mutation in the 
gene encoding for ADAMTS13 was identified as the 
cause of history of recurrent acute renal failure as-
sociated  with  microangiopathic  hemolytic  anemia 
and thrombocytopenia [31]. ADAMTS13 deficiency 
was suggested to be a cause of chronic kidney dis-
ease when features of thrombotic microangiopathy 
are present on renal biopsy [32]. Lately, decreased 
ADAMTS13 was found to be associated with a poor 
prognosis in sepsis-induced organ failure [33, 34]. 
ADAMTS13(-/-) mice develop more severe inflam-
matory responses,  leading  to increased  ischemia 
reperfusion injury and formation of atherosclerosis 
[28].
In conclusion, the present study has reported 
that insulin does not participate in the regulation of 
ADAMTS13 level and/or activity in OUMS-27 chon-
drosarcoma cells. This study will provide a new in-
sight for understanding action of insulin on chon-
drogenesis, chondrocyte action, and the levels of 
ADAMTS proteins and RNA in cellular level.
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